AQST News and Press, Aquestive Therapeutics Inc. From 08/31/22

WARREN, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (Nasdaq: AQST), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, announced today that the managemen...

Aquestive Therapeutics ( NASDAQ: AQST ), a company focused on different formulations of drugs announced Wednesday that the FDA granted tentative approval for Libervant (diazepam) Buccal Film for acute treatment of seizure in epilepsy patients aged 12 years and older. Speci...

Libervant provided tentative approval from the FDA for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity Libervant U.S. Market Access currently subject to the expiration of Valtoco® orphan drug market exclusivity Company hosts conference...

3 Ways That Inflation Impacts Investing in Penny Stocks When it comes to trading penny stocks, investors need to know everything that is going on in the stock market. Inflation is a huge factor when it comes to penny stocks , especially in the past few months. When inflation rates a...

Appoints Timothy E. Morris, a veteran biotech executive with over 35 years of experience in executive and financial leadership, to Board of Directors Names Kenneth Truitt, M.D., with over 25 years of clinical and regulatory experience across biotechnology and large pharmaceu...

Euro Tech Holdings Company ( CLWT ) +39% . SilverSun Technologies ( SSNT ) +28% . Aethlon Medical ( AEMD ) +19% CEO Chuck Fisher on Q1 2023 Results - Earnings Call Transcript. The Trade Desk ( TTD ) +16% Inc. 2023 Q2 - Results - Earnings C...

Image source: The Motley Fool. Aquestive Therapeutics, Inc. (NASDAQ: AQST) Q2 2022 Earnings Call Aug 03, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Aquestive Therapeutics, Inc. (AQST) Q2 2022 Earnings Call Tran...

Aquestive Therapeutics, Inc. (AQST) Q2 2022 Earnings Conference Call August 03, 2022 08:00 AM ET Company Participants Bennett Watson - ICR Westwicke, Investor Relations Dan Barber - Chief Executive Officer Ernie Toth - Chief Financial Officer Dr. Steve Wargac...

Aquestive Therapeutics ( NASDAQ: AQST ) stock lost as much as 8.2% to $0.81 in Wednesday trading, after the pharmaceutical company reported a Y/Y fall in Q2 revenue and and a wider loss, while also raising its FY revenue and earnings guidance. AQST after hours on Tuesd...

Aquestive Therapeutics press release ( NASDAQ: AQST ): Q2 GAAP EPS of -$0.36 in-line. Revenue of $13.27M (-13.5% Y/Y) beats by $2.7M . 2022 Guidance: Total revenue (in millions) - $46 to $49M from prior forecast $42 to $47M($46.46M consensus) For fur...